Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ABT — Abbott Laboratories
NYSE
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

APR 16, 2026
REVENUE
$11.16B -2.6%
NET MARGIN
9.6% -5.9 PTS
EPS
$0.62 -39.2%
FREE CASH FLOW
$916.0M -65.1%

No summary has been written for this call yet.